FDA.reportPublic FDA data

belzutifan 40 MG Oral Tablet

RxCUI
2567231
RxNorm name
belzutifan 40 MG Oral Tablet
Display name
belzutifan 40 MG Oral Tablet
Full name
belzutifan 40 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
13e15ee0-d679-4fa9-9430-e2e2170474dabelzutifan 40 MG Oral Tablet [PSN] · belzutifan 40 MG Oral Tablet [SCD]211These highlights do not include all the information needed to use WELIREG safely and effectively. See full prescribing information for WELIREG. WELIREG ® (belzutifan) tablets, for oral use Initial U.S. Approval: 202120250514